Skip to main content
. 2016 Jun 16;11(6):e0157693. doi: 10.1371/journal.pone.0157693

Table 2. Distribution of resistance determinants to trimethoprim/sulfamethoxazole resistance in clinical Stenotrophomonas maltophilia isolates.

year (n) genes SXT MIC(mg/L)
qacEΔ1-sul1(%) sul2(%) dfra1(%) dfra5(%) dfra12(%) dfra17(%) dfra27(%) int1(%) S(%) R(%) range MIC50 MIC90
2005(26) 11(42.3) 2(7.7) 1(3.8) 11(42.3) 21(80.8) 5(19.2) 0.25/4.75-32/608 0.25/4.75 8/152
2006(26) 12(46.2) 2(7.7) 1(3.8) 2(7.7) 13(50) 18(69.2) 8(30.8) 0.25/4.75-32/608 0.25/4.75 16/304
2007(26) 18(69.2) 3(11.5) 1(3.8) 2(7.7) 2(7.7) 17(65.4) 17(65.4) 9(34.6) 0.25/4.75-32/608 0.25/4.75 16/304
2008(24) 13(54.2) 6(25) 3(12.5) 3(12.5) 15(62.5) 16(66.7) 8(33.3) 0.25/4.75-32/608 0.25/4.75 32/608
2009(43) 23(53.5) 5(11.6) 5(11.6) 26(60.5) 30(69.8) 13(30.2) 0.25/4.75-32/608 0.5/9.5 32/608
2010(43) 23(53.5) 15(34.9) 2(4.7) 3(7.0) 2(4.7) 35(81.4) 24(55.8) 19(44.2) 0.25/4.75-32/608 0.5/9.5 32/608
2011(20) 12(60) 10(50) 1(5) 1(5) 4(20) 2(10) 3(15) 17(85) 12(60) 8(40) 0.25/4.75-32/608 1/19 32/608
2012(32) 17(53.1) 16(50) 1(3.1) 1(3.1) 4(12.5) 5(15.6) 4(12.5) 30(93.8) 15(46.9) 17(53.1) 0.25/4.75-32/608 4/76 32/608
2013(28) 25(89.3) 13(46.4) 1(3.6) 6(21.4) 5(17.9) 1(3.6) 24(85.7) 14(50) 14(50) 0.25/4.75-32/608 4/76 32/608
2014(32) 25(78.1) 7(21.9) 5(15.6) 3(9.4) 30(93.7) 17(53.1) 15(46.9) 0.25/4.75-32/608 4/76 32/608
Total (300) 179(59.7) 77(25.7) 4(1.3) 4(1.3) 35(11.7) 25(8.3) 8(2.7) 218(72.7) 184(61.4) 116(38.7) 0.25/4.75-32/608 0.5/9.5 32/608

SXT, trimethoprim-sulfamethoxazole; S, susceptible; R, resistant; MIC, Minimal inhibitory concentration; MIC50, the concentration needed to inhibit 50% of the strains; MIC90, the concentration needed to inhibit 90% of the strains